Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients

NCT06054529

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: AdventHealth Translational Research Institute Orlando, Florida, United States

View Trial Details

Active, Not Recruiting

Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma

NCT06863870

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Active, Not Recruiting

Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

NCT05736523

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Intermountain Medical Center Murray, Utah, United States

Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Active, Not Recruiting

Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM

NCT03452579

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Active, Not Recruiting

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

NCT05732805

Conditions: Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +16 more
Locations: Healthcare Institution "Bobruisk Interdistrict Oncological Dispensary" Babruysk, Belarus

Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus

Health care institution "Grodno University Clinic" Grodno, Belarus

Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus

View all 63 locations

View Trial Details

Active, Not Recruiting

Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists

NCT03412058

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations: Institut Bergonie Bordeaux, France

Centre Hospitalier de Caen Caen, France

Centre Jean Perrin Clermont-Ferrand, France

Centre Hospitalier Inter. de Creteil Créteil, France

View all 19 locations

View Trial Details

Active, Not Recruiting

Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas

NCT03181477

Conditions: Astrocytoma, Glioblastoma, Glioblastoma, Adult, +8 more
Locations: CHU Amiens Picardie Amiens, France

CHU Besançon Besançon, France

Centre Georges François Leclerc Dijon, France

Centre d'oncologie et de radiothérapie Mâcon, France

View Trial Details

Active, Not Recruiting

AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma

NCT04881032

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: CHU de Brest Brest, France

Centre Jean Perrin Clermont-Ferrand, France

CHU de Grenoble Grenoble, France

Centre Léon Berard Lyon, France

View Trial Details

Active, Not Recruiting

Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors

NCT05168631

Conditions: Carcinoma;Endocrine, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Universidade Federal do Ceará/HOSPITAL UNIVERSITARIO WALTER CANTIDIO Fortaleza, Ceará, Brazil

Ensino E Terapia de Inovacao Clinica Amo - Etica Salvador, Estado de Bahia, Brazil

Hospital Sírio Libanês Brasília Brasília, Federal District, Brazil

Hospital Moinhos de Vento Porto Alegre, Rio Grande do Sul, Brazil

View Trial Details

Active, Not Recruiting

PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas

NCT05473923

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations: Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions